Gut microbiome is associated with recurrence-free survival in patients with resected Stage IIIB-D or Stage IV melanoma treated with immune checkpoint inhibitors
M. Usyk, R. B. Hayes, R. Knight, A. Gonzalez, H. Li, I. Osman, J. S. Weber, J. Ahn
The paper identifies gut microbiome taxonomic markers associated with recurrence in melanoma patients treated with immune checkpoint inhibitors, showing generalizability across regions when GMB composition is matched.
bioRxiv · Apr 16, 2024 · PreprintCancer Biology